SYK
NYSE / NasdaqHealthcareStryker Corporation
Apenas dados básicos. O foco do Case de Valor é o mercado de ações brasileiras. Análises completas (Saúde Financeira, Preço Teto, demonstrativos) estão disponíveis para as Ações B3.
Indicadores principais
Market Cap
US$ 118,7 B
P/L
32,1×
Preço / Lucro
P/L Futuro
18,5×
Forward P/E
P/VP
4,9×
Preço / Valor Patr.
Margem Líquida
14,4%
ROE
16,5%
Retorno s/ patrimônio
Dividend Yield
1,1%
12 meses
Setor
Healthcare
Medical Devices
Histórico de Preço
Performance
1 dia
—
1 sem
—
1 mês
—
3 meses
—
6 meses
—
1 ano
—
5 anos
—
Dados gerais
Descrição
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Dados via Yahoo Finance (cotação de fechamento/EOD, com possível atraso). Conteúdo informativo — não constitui recomendação de investimento.